CLINICAL-EXPERIENCES WITH INVITRO CYTOSTATIC SENSITIVITY TESTING OF MYELOMA PARENT CELLS

被引：0
|
作者：
LUDWIG, H [1 ]
FRITZ, E [1 ]
机构：
[1] VIENNA UNIV,MED 2 KLIN,A-1090 VIENNA,AUSTRIA
来源：
ACTA MEDICA AUSTRIACA | 1981年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 43 条
  • [31] In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells
    da Luz, Raquel Inocencio
    Vermeersch, Marieke
    Dujardin, Jean-Claude
    Cos, Paul
    Maes, Louis
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (12) : 5197 - 5203
  • [32] Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories
    Shetty, Shashirekha
    Siady, Marion
    Mallempati, Kalyan C.
    Wilson, Andrew
    Poarch, Jeff
    Chandler, Brandon
    Gray, Judy
    Salama, Mohamed E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (03) : 274 - 281
  • [33] Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories
    Shashirekha Shetty
    Marion Siady
    Kalyan C. Mallempati
    Andrew Wilson
    Jeff Poarch
    Brandon Chandler
    Judy Gray
    Mohamed E. Salama
    International Journal of Hematology, 2012, 95 : 274 - 281
  • [34] THE CLINICAL IMPLICATION AND PROGNOSTIC VALUE OF INVITRO L-ASCORBIC-ACID (LAA) SENSITIVITY OF CLONOGENIC CELLS IN MYELODYSPLASTIC SYNDROME (MDS)
    PARK, CH
    KIMLER, BF
    BODENSTEINER, D
    LYNCH, SR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 211 - 211
  • [35] CLINICAL-VALUE OF INVITRO DRUG SENSITIVITY TESTING BASED ON SHORT-TERM EFFECTS ON DNA AND RNA-METABOLISM IN OVARIAN-CANCER
    KHOO, SK
    HURST, T
    WEBB, MJ
    DICKIE, G
    KEARSLEY, J
    PARSONS, PG
    MACKAY, EV
    JOURNAL OF SURGICAL ONCOLOGY, 1989, 41 (03) : 201 - 205
  • [36] INVITRO SENSITIVITY OF MYELOBLAST CLONOGENIC CELLS TO DOXORUBICIN, ACLACINOMYCIN-A, AND 4'-O-TETRAPYRANYL-DOXORUBICIN - CORRELATIONS WITH CLINICAL-RESPONSES
    GEORGOULIAS, V
    ISKANDAR, YL
    AMESLAND, F
    RIBAUD, P
    MATHE, G
    JASMIN, C
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) : 1215 - 1222
  • [37] FEASIBILITY OF INVITRO GROWTH AND CHEMOSENSITIVITY TESTING (CT) OF SMALL CELL LUNG-CANCER (SCLC) CELLS IN A PROSPECTIVE CLINICAL-TRIAL
    IHDE, DC
    OIE, H
    RUSSELL, EK
    LINNOILA, I
    CARNEY, DN
    MINNA, JD
    GAZDAR, AF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 369 - 369
  • [38] Molecular profiles of sensitivity or resistance of multiple myeloma (MM) cells to conventional and novel anti-myeloma agents: Clinical implications for rationale design of strategies to overcome drug-resistance in MM.
    Mitsiades, CS
    Mitsiades, N
    McMullan, CJ
    Poulaki, V
    Hideshima, T
    Chauhan, D
    Munshi, NC
    Joseph, M
    Libermann, TA
    Anderson, KC
    BLOOD, 2003, 102 (11) : 189A - 189A
  • [39] PHASE-I CLINICAL-TRIAL OF ORALLY-ADMINISTERED 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) WITH PHARMACOKINETIC AND INVITRO DRUG SENSITIVITY TESTING IN CHILDREN WITH REFRACTORY LEUKEMIA
    PUI, CH
    DEGRAAF, SSN
    DOW, LW
    RODMAN, JH
    EVANS, WE
    ALPERT, BS
    MURPHY, SB
    CANCER RESEARCH, 1988, 48 (18) : 5348 - 5352
  • [40] CHEMOTHERAPY SENSITIVITY ASSESSMENT OF LEUKEMIC COLONY-FORMING CELLS WITH INVITRO SIMULTANEOUS EXPOSURE TO MULTIPLE-DRUGS - CLINICAL CORRELATIONS IN ACUTE NONLYMPHOCYTIC LEUKEMIA
    PARK, CH
    AMARE, M
    MORRISON, FS
    MALONEY, TR
    GOODWIN, JW
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1257 - 1261
12345